Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04706221 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients
A NA study of Blood Loss, sponsored by Zynex Monitoring Solutions.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT04706221: Completed NA study of Blood Loss, sponsored by Zynex Monitoring Solutions.
NCT04706221 is a NA study of Blood Loss that has completed, run by Zynex Monitoring Solutions. The registered enrollment target is 200 participants, above the 165-participant average among 9 other Blood Loss trials with a reported enrollment target (21% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04706221, a NA study of Blood Loss, has completed, sponsored by Zynex Monitoring Solutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective is to evaluate the the changes in the Relative Index in post abdominal or pelvic surgery patients on the Cardiac Monitor Model CM-1500.
Primary Outcome
The primary objective is to evaluate changes in the Relative Index (RI) in post-abdominal or pelvic surgery patients (Laparoscopic or Open). The CM-1500 monitors parameters which are indicative of relative changes in fluid volume in adult patients. The Relative Index is an investigational value which utilizes proprietary algorithms to combine the relative changes of each measured parameter into a single value. The Relative Index is graded on a scale where 100 indicates a patient's baseline, and
Conditions Studied
Interventions
- DEVICE CM-1500
Study Locations (1)
North Carolina
- Wake Forest University - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2021-11-29 |
| Phase | NA |
What the finished NCT04706221 record still lists
NCT04706221 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 165-participant average among 9 other Blood Loss trials with a reported enrollment target (21% higher).
The record links to 1 condition, with Blood Loss appearing as the primary indexed condition, and to 1 intervention - of which CM-1500 is the first listed.
NCT04706221 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04706221 about?
NCT04706221 is a clinical study titled "Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients". The primary objective is to evaluate the the changes in the Relative Index in post abdominal or pelvic surgery patients on the Cardiac Monitor Model CM-1500.
What is the current status of trial NCT04706221?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2021-01-15. Estimated completion is 2021-11-29.
What conditions does trial NCT04706221 study?
This clinical trial studies the following conditions: Blood Loss.
What interventions are being tested in trial NCT04706221?
The interventions under investigation include: CM-1500 (DEVICE).
Who is sponsoring clinical trial NCT04706221?
This trial is sponsored by Zynex Monitoring Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04706221 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04706221's enrollment target sits among peer trials
200 5th of 9 higher than 5 of 9 other Blood Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LBNP Tolerance With Skin Warming After Exercise Cold Stress
ACTIVE NOT RECRUITING · NA
-
Frozen Red Blood Cell Transfusions in Trauma Patients
COMPLETED · NA
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
RECRUITING · Phase 4
-
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
ACTIVE NOT RECRUITING · Phase 4
-
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI